The impact of the Canada-United States-Mexico Agreement on prescription drug expenditures in Canada.: YN5-176/2019E-PDF
"The Canada-United States-Mexico Agreement (CUSMA) provides an extension to the term of protection for data resulting from drug trials. The extension applies to a category of pharmaceuticals known as innovative biologics. These are drugs with complex structures that have become increasingly popular. In recent years, pharmaceutical companies have been seeking extensions to the terms of data protection for such biologics to bolster the market exclusivity given by patents"--Executive summary, page 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.871535&sl=0
| Department/Agency | Canada. Office of the Parliamentary Budget Officer. |
|---|---|
| Title | The impact of the Canada-United States-Mexico Agreement on prescription drug expenditures in Canada. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Incidence de l'Accord Canada-États-Unis-Mexique sur les dépenses en médicaments d'ordonnance au Canada. Cover title. Includes bibliographical references. |
| Publishing information | Ottawa, Canada : Office of the Parliamentary Budget Officer = Bureau du directeur parlementaire du budget, 2 April 2019. |
| Description | 1 online resource (37 pages). |
| Catalogue number |
|
| Subject terms | Trade agreements Drugs |